| EPB0227 | Factors associated with viral rebound among PLHIV who achieved viral suppression in Eswatini: a retrospective cohort study | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0226 | Changes in weight and body mass index associated with dolutegravir- and non-dolutegravir-based antiretroviral treatment regimens: a longitudinal analysis | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0225 | A Site-driven CQI intervention improves advanced HIV disease screening coverage among newly diagnosed people living with HIV in Malawi | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0224 | Association of oral lead-in and persistence on cabotegravir and rilpivirine long-acting in ‘real-life’ | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0223 | Real-world utilization and effectiveness of long-acting cabotegravir+rilpivirine in the United States: Trio Cohort study | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0222 | A Bayesian update on discontinuation of cabotegravir and rilpivirine using cohort data | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0221 | Cabotegravir + rilpivirine long-acting outcomes by sex at birth, age, race, and body mass index: a subgroup analysis of the Phase 3b SOLAR study | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0220 | Probability of single tablet regimens BIC/FTC/TAF, E/C/F/TAF, RPV/FTC/TAF, DTG/RPV or DTG/ABC/3TC discontinuation at 18 months in real life settings in the ANRS-CO3 - AquiVIH-NA cohort | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0219 | Islatravir (MK-8591) has no meaningful effect on the pharmacokinetics of atorvastatin and metformin following coadministration | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0218 | Switching to dolutegravir/lamivudine (DTG/3TC) is non-inferior to continuing tenofovir alafenamide (TAF)-based regimens at Week 196: TANGO subgroup analyses | E-poster | Antiretroviral therapies and clinical issues in adults |